Advising Waivgen on its acquisition by Synechron
2025年10月21日
Meg specialises in US corporate and securities law, advising on, among other things, general corporate matters and venture capital financing transactions, particularly in the life sciences sector.
Meg's day-to-day work focuses on advising life sciences and technology companies at all stages of development, with a particular focus on advising both companies and investors in venture capital financing transactions, from early-stage to late-stage. She also works closely with entrepreneurs to counsel them through initial company formation issues, day-to-day corporate governance matters, and liquidity events.
Prior to joining Taylor Wessing, she spent ten years at a top-tier firm in California, where she represented prominent US and international companies and funds in life sciences and technology financing transactions and exits. She is a current member of the California Bar.
Meg particularly enjoys advising clients on complex US and cross-border venture financing transactions.
